Literature DB >> 10624349

CT guided interstitial high dose rate brachytherapy for recurrent malignant gliomas.

C Kolotas1, G Birn, D Baltas, B Rogge, P Ulrich, N Zamboglou.   

Abstract

This paper describes the technique and preliminary results of high dose rate (HDR) interstitial brachytherapy for recurrent grade III and grade IV gliomas. Although in the initial treatment of malignant gliomas brachytherapy has been shown to give better results than external beam therapy, this has previously always been with low dose rate (LDR) brachytherapy. Stereotactic frames are used for interstitial LDR brachytherapy but a CT image-guided technique does not require such a frame. The survival rates for our initial 53 patients do not significantly differ from LDR results. However, using HDR there are several advantages, including a much shorter treatment time with HDR than LDR and better patient comfort. HDR also allows better individualized optimization of the treatment than LDR.

Entities:  

Mesh:

Year:  1999        PMID: 10624349     DOI: 10.1259/bjr.72.860.10624349

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  8 in total

Review 1.  Brachytherapy for brain tumors.

Authors:  Todd W Vitaz; Peter C Warnke; Viviane Tabar; Philip H Gutin
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

Review 2.  Controversies concerning the application of brachytherapy in central nervous system tumors.

Authors:  Bo-Lin Liu; Jin-Xiang Cheng; Xiang Zhang; Wei Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-02       Impact factor: 4.553

Review 3.  The role of brachytherapy in the treatment of glioblastoma multiforme.

Authors:  Eric Barbarite; Justin T Sick; Emmanuel Berchmans; Amade Bregy; Ashish H Shah; Nagy Elsayyad; Ricardo J Komotar
Journal:  Neurosurg Rev       Date:  2016-05-16       Impact factor: 3.042

4.  Combined salvage therapies for recurrent glioblastoma multiforme: evaluation of an interdisciplinary treatment algorithm.

Authors:  Eleftherios Archavlis; Nikolaos Tselis; Gerhard Birn; Peter Ulrich; Nikolaos Zamboglou
Journal:  J Neurooncol       Date:  2014-06-20       Impact factor: 4.130

5.  Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme.

Authors:  Georgios Chatzikonstantinou; Peter Ulrich; Eleftherios Archavlis; Nikolaos Zamboglou; Iosif Strouthos; Eleni Zoga; Dimos Baltas; Nikolaos Tselis
Journal:  J Contemp Brachytherapy       Date:  2019-06-28

6.  Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme.

Authors:  Eleftherios Archavlis; Nikolaos Tselis; Gerhard Birn; Peter Ulrich; Dimos Baltas; Nikolaos Zamboglou
Journal:  BMJ Open       Date:  2013-03-15       Impact factor: 2.692

7.  Accuracy evaluation of a 3D-printed individual template for needle guidance in head and neck brachytherapy.

Authors:  Ming-Wei Huang; Jian-Guo Zhang; Lei Zheng; Shu-Ming Liu; Guang-Yan Yu
Journal:  J Radiat Res       Date:  2016-07-15       Impact factor: 2.724

8.  A novel three-dimensional template combined with MR-guided 125I brachytherapy for recurrent glioblastoma.

Authors:  Xiangmeng He; Ming Liu; Menglong Zhang; Roberto Blanco Sequeiros; Yujun Xu; Ligang Wang; Chao Liu; Qingwen Wang; Kai Zhang; Chengli Li
Journal:  Radiat Oncol       Date:  2020-06-08       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.